Sort
82,697 grants matching “vaccine development”
Hematopoietic Cell Transplantation for Hematologic Malignancies
$2,908,648Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL CORE
$2,907,143Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2021 · AI
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$2,906,247Amy E Hughes · Ut Southwestern Medical Center · UM1 · FY2022 · CA
Pulmonary responses to Bioweapon Category A Pathogens
$2,905,953Clifford Rick Lyons · University Of New Mexico · P01 · FY2006 · AI
Role of antigen-specific T cell responses in the control of TB
$2,905,098Henry M Blumberg · Emory University · U19 · FY2018 · AI
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,904,866Rachel R. Caspi · National Eye Institute · Z01 · FY2008 · EY
NIAID VIROLOGY QUALITY ASSURANCE
$2,904,751James Bremer · Rush University Medical Center · N01 · FY2013 · AI
NIEHS Cryo-EM Core Facility
$2,904,674Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2020 · ES
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
$2,902,791Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
Biodefense vaccine for pandemic influenza
$2,902,252Vical, Inc. · UC1 · FY2005 · AI
Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines
$2,901,850Michael Gale · University Of Washington · N01 · FY2016 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM
$2,900,000Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$2,899,686Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2008 · AI
Vaccine Induced Immunity in the Young and Aged
$2,899,511Rafi Ahmed · Emory University · U19 · FY2016 · AI
Mucosal Immunity, Vaccines and Microbiota Interplay in Humans and Animal
$2,899,170Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2011 · AI
University of New Mexico Interdisciplinary HPV Prevention Center
$2,899,170Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2012 · AI
Role of antigen-specific T cell responses in the control of TB
$2,898,702Henry M Blumberg · Emory University · U19 · FY2017 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,898,581Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2018 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,898,581Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2016 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,898,581Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2015 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,898,581Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2017 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$2,898,518Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
DNA Vaccine for Induction of Mucosal Immunity
$2,898,353David B. Weiner · University Of Pennsylvania · P01 · FY2011 · AI
Development of a Next Generation Anthrax Vaccine, dmPA7909
$2,896,688Sukjoon Park · Emergent Product Development Gaithersbur · U01 · FY2010 · AI
Infectious Diseases Research Technologies Core - RML
$2,892,879Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2011 · AI